Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannsoporfin with Phototherapy in Neonates with Hyperbilirubinemia
NCT01887327Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of stannsoporfin in neonatal hyperbilirubinemia, sponsored by Mallinckrodt Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
stannsoporfin
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT01887327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887327.